T Cell News and Research

Latest T Cell News and Research

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

Inactivating a protective molecule in leukemic cells to make them more vulnerable to chemotherapy might also make healthy blood-forming cells more sensitive to the toxic effects of those same drugs.

19 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

Manipulation of the body’s own natural killer cells to destroy cells containing the HIV virus

Current treatments for HIV block the virus from replicating, but don’t kill the cells that contain HIV. The existence of these HIV-harboring cells -- often called the “latent” or “resting reservoir” -- is regarded by many to be the main obstacle to finding a cure for HIV.

18 May 2004

Scientists move closer toward treatment for degenerative diseases

Scientists at McGill University's Faculty of Medicine have discovered a key step that will provide new targets for treatments of many degenerative diseases such as Alzheimer's, Cystic Fibrosis and Diabetes.

17 May 2004

Scientists have identified a compound that halts the activity of a deadly toxin called anthrax

University of Chicago scientists have identified a compound that halts the activity of a deadly toxin called anthrax lethal factor in laboratory tests. Nature Biotechnology will publish the findings online on May 16 and in the June issue of the journal's print edition.

17 May 2004

Inheriting the wrong version of a gene called CHEK2 doubles a woman's risk of developing breast cancer

Inheriting the wrong version of a gene called CHEK2 doubles a woman's risk of developing breast cancer, Cancer Research UK scientists confirm in a major new international study published in the June edition of the American Journal of Human Genetics.

17 May 2004

Researchers demonstrate wearable electronics to aid health and fashion

Soon you may be wearing your computer, or elements of it, according to a team of researchers and designers at Arizona State University. The era of smart bodysuits is about to begin.

17 May 2004

Glucose metabolism could be used to selectively destroy cancer cells

Scientists have known for decades that cancer cells consume more glucose than normal cells. A longstanding assumption that the excess glucose metabolism was needed to make energy has not been borne out by research studies.

15 May 2004

Cancer-causing gene identified that may play a key role in the development of leukemia and other cancers

Using genetically engineered mice, researchers at the Johns Hopkins Children's Center have identified a gene that functions as a cancer-causing gene (or oncogene) and may play a key role in the development of leukemia and other cancers in children and adults.

15 May 2004

New device lab-on-a-chip sensor to detect milk contamination

Whitaker investigator David Beebe, Ph.D., of the University of Wisconsin-Madison has developed a process to make on-demand, miniature sensors for a wide variety of poisons, including naturally occurring contaminants and intentionally introduced toxins.

15 May 2004

Vitamin discovery offers clues for cancer chemotherapy

NH-Dartmouth Medical School cancer researchers, in a fusion of biochemistry and genetics, have discovered a new vitamin in a molecular pathway central to such vital processes as gene regulation, metabolism and aging. And, they found that milk contains this nutrient.

15 May 2004

3 people with drug-resistant HIV become first to undergo a new form of gene therapy

The idea is to use a modified form of HIV to deliver an "antisense" gene to the immune cells that HIV infects. This is integrated into the cells' genome, and stays there until a cell is infected. Then it is switched on, and produces RNA complementary to the "sense" RNA encoding a viral protein. In theory, the RNAs should bind together, blocking viral replication.

14 May 2004

Australian researchers identify potential target to fight tumours

Dr Guishui Zhang and Associate Professor Levon Khachigian, from the Centre for Vascular Research, and Dr Nick Di Girolamo of the School of Medical Sciences were part of a team which suppressed a protein in the cells lining blood vessels.

14 May 2004

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

The study will include a basic research component to examine the roles of B and T cells, white blood cells in the immune system, in triggering lupus symptoms.

14 May 2004

New research program to focus on human beta cell regeneration and its potential role to cure type-1 diabetes

The Juvenile Diabetes Research Foundation (JDRF) have announced a new program today called the Regeneration of Beta Cell Function (RBCF) to focus on human beta cell regeneration and its potential role to cure type-1 diabetes.

14 May 2004

Researchers identify new genes that control the formation of cilia found throughout the human body

Howard Hughes Medical Institute researchers have used a combination of brainpower and computer power to identify a multitude of new genes that control the formation of tiny, hair-like cilia that stipple the surfaces of many organs in a wide variety of creatures.

14 May 2004

Key hole colon surgery effective

When performed by experienced surgeons, minimally invasive laparoscopic surgery is a safe and effective alternative to standard open surgery for most patients with cancer that is confined to the colon.

13 May 2004

Biochip technology to revolutionise the pharmaceutical industry

Advancements in biotechnology have culminated in its integration with semiconductor technologies such as micro-electromechanical systems, resulting in the evolution of biochips. Biochips provide pharma companies with sophisticated tools for speedy development of drugs and accurate diagnosis and understanding of biological mechanisms.

13 May 2004

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Maxim Pharmaceuticals has announced the results of an international Phase 3 clinical trial testing the combination of Ceplene (TM) plus interleukin-2 (IL-2) in 320 patients with acute myeloid leukemia (AML) in complete remission.

12 May 2004

Nanobodies herald a new era in cancer therapy

Cancer, along with heart and vascular disease, is the major cause of death in the Western world. The first generation of anti-cancer drugs has already saved many lives, but because these medicines are non-specific they also often have severe side effects.

12 May 2004

T Cell News and Research

Latest T Cell News and Research

Inactivating a protective molecule may help chemotherapy for leukemia but harm bone marrow

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Manipulation of the body’s own natural killer cells to destroy cells containing the HIV virus

Scientists move closer toward treatment for degenerative diseases

Scientists have identified a compound that halts the activity of a deadly toxin called anthrax

Inheriting the wrong version of a gene called CHEK2 doubles a woman's risk of developing breast cancer

Researchers demonstrate wearable electronics to aid health and fashion

Glucose metabolism could be used to selectively destroy cancer cells

Cancer-causing gene identified that may play a key role in the development of leukemia and other cancers

New device lab-on-a-chip sensor to detect milk contamination

Vitamin discovery offers clues for cancer chemotherapy

3 people with drug-resistant HIV become first to undergo a new form of gene therapy

Australian researchers identify potential target to fight tumours

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

New research program to focus on human beta cell regeneration and its potential role to cure type-1 diabetes

Researchers identify new genes that control the formation of cilia found throughout the human body

Key hole colon surgery effective

Biochip technology to revolutionise the pharmaceutical industry

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Nanobodies herald a new era in cancer therapy

Immunology eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in